vancomycin has been researched along with Cerebral Ventriculitis in 19 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 11 (57.89) | 24.3611 |
2020's | 8 (42.11) | 2.80 |
Authors | Studies |
---|---|
Cieslinski, J; Dos Santos Oliveira, D; Gasparetto, J; Ribeiro, VST; Telles, JP; Tuon, FF; Yamada, CH | 1 |
Brynjarsson, H; Helgason, EA; Olafsson, IH; Oskarsdottir, T; Thors, V | 1 |
Kong, Y; Ma, J; Shi, G; Tian, Y; Ye, Y | 1 |
Antcliffe, DB; Arkell, P; Barnes, SC; Gilchrist, M; Holmes, A; Noel, AR; Rawson, TM; Watkins, K; Wilson, M; Wilson, R | 1 |
Barco, S; Castagnola, E; Parodi, A; Sette, C | 1 |
Bode-Böger, SM; Czorlich, P; Grensemann, J; Kluge, S; König, C; Martens-Lobenhoffer, J; Westphal, M | 1 |
Albur, M; Heep, A; Kloprogge, F; Parasuraman, JM; Standing, JF | 1 |
Arnemann, PH; Ertmer, C; Gastine, S; Hempel, G; Hessler, M; Jalusic, KO; Kampmeier, TG; Spiekermann, C | 1 |
Cain, AN; Hultén, KG; Kaplan, SL; Mason, EO; Vallejo, JG | 1 |
Bhimraj, A; Bleck, TP; Byers, K; Hasbun, R; Kaplan, SL; Scheld, WM; Tunkel, AR; van de Beek, D; Zunt, JR | 1 |
Daniels, L; Marx, A; Miller, MB; Weber, DJ | 1 |
Albur, M; Fellows, G; Heep, A; Parasuraman, JM | 1 |
Brophy, GM; Clark, S; Cook, AM; Giarratano, M; Gonzales, C; Kurczewski, L; Lewin, JJ; Makii, J; Merola, D; Neyens, R; Peppard, WJ; Rowe, AS; Tesoro, EP; Zaniewski, A; Ziai, WC | 1 |
Blassmann, U; Briegel, J; Frey, OR; Hope, W; Huge, V; Roehr, AC; Thon, N; Vetter-Kerkhoff, C | 1 |
Cocito, L; Marinelli, L; Trompetto, C | 1 |
Bui, CJ; Steele, RW; Weiner, GM | 1 |
Pacheco, SM; Patel, JA; Postelnick, M; Sutton, S | 1 |
Chow, I; Ensom, MH; Mabasa, VH; Ng, K | 1 |
Lipman, J; Lonsdale, DO; Roberts, JA; Udy, AA | 1 |
1 review(s) available for vancomycin and Cerebral Ventriculitis
Article | Year |
---|---|
Systematic review of efficacy, pharmacokinetics, and administration of intraventricular vancomycin in adults.
Topics: Anti-Bacterial Agents; Cerebral Ventriculitis; Humans; Injections, Intraventricular; Meningoencephalitis; Vancomycin | 2014 |
18 other study(ies) available for vancomycin and Cerebral Ventriculitis
Article | Year |
---|---|
Cerebrospinal Fluid Penetration of Vancomycin During Continuous Infusion Therapy in Patients With Nosocomial Ventriculitis.
Topics: Anti-Bacterial Agents; Cerebral Ventriculitis; Cross Infection; Humans; Intensive Care Units; Vancomycin | 2021 |
Intraventricular Vancomycin Treatment for Shunt-related Ventriculitis Caused by Methicillin-resistant Staphylococcus Aureus in a Preterm Infant: A Case Report.
Topics: Anti-Bacterial Agents; Cerebral Ventriculitis; Encephalitis; Humans; Hydrocephalus; Infant; Infant, Newborn; Infant, Premature; Methicillin-Resistant Staphylococcus aureus; Myelitis; Vancomycin; Ventriculoperitoneal Shunt | 2022 |
Trends of Antimicrobial Susceptibility in Clinically Significant Coagulase-Negative Staphylococci Isolated from Cerebrospinal Fluid Cultures in Neurosurgical Adults: a Nine-Year Analysis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Proteins; Cerebral Ventriculitis; Cerebrospinal Fluid; Coagulase; Cross Infection; Drug Resistance, Bacterial; Female; Humans; Linezolid; Male; Meningitis, Bacterial; Microbial Sensitivity Tests; Middle Aged; Staphylococcal Infections; Staphylococcus; Vancomycin; Young Adult | 2022 |
A pilot observational study of CSF vancomycin therapeutic drug monitoring during the treatment of nosocomial ventriculitis.
Topics: Anti-Bacterial Agents; Cerebral Ventriculitis; Cross Infection; Drug Monitoring; Encephalitis; Humans; Vancomycin | 2022 |
Ventriculitis and meningitis: by methicillin-resistant
Topics: Anti-Bacterial Agents; Cerebral Ventriculitis; Humans; Linezolid; Meningitis; Methicillin Resistance; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus epidermidis; Vancomycin | 2022 |
Cerebrospinal fluid penetration of fosfomycin in patients with ventriculitis: an observational study.
Topics: Adult; Anti-Bacterial Agents; Cerebral Ventriculitis; Cerebrospinal Fluid; Fosfomycin; Humans; Meropenem; Vancomycin | 2023 |
Population Pharmacokinetics of Intraventricular Vancomycin in Neonatal Ventriculitis, A Preterm Pilot Study.
Topics: Anti-Bacterial Agents; Cerebral Ventriculitis; Humans; Infant; Infant, Newborn; Infant, Premature; Pilot Projects; Prospective Studies; Vancomycin | 2021 |
Population pharmacokinetics of vancomycin in patients with external ventricular drain-associated ventriculitis.
Topics: Anti-Bacterial Agents; Area Under Curve; Cerebral Ventriculitis; Drainage; Humans; Vancomycin | 2021 |
Staphylococcus aureus Central Nervous System Infections in Children.
Topics: Adolescent; Anti-Bacterial Agents; Cerebral Ventriculitis; Child; Child, Preschool; Female; Humans; Infant; Infant, Newborn; Male; Meningitis, Bacterial; Methicillin-Resistant Staphylococcus aureus; Retrospective Studies; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2017 |
Reply to Marx et al.
Topics: Cerebral Ventriculitis; Humans; Judgment; Meningitis; Microbial Sensitivity Tests; Vancomycin | 2017 |
Vancomycin Minimum Inhibitory Concentration Is Not a Substitute for Clinical Judgment: Response to Healthcare-Associated Ventriculitis and Meningitis.
Topics: Cerebral Ventriculitis; Humans; Judgment; Meningitis; Microbial Sensitivity Tests; Vancomycin | 2017 |
Monitoring intraventricular vancomycin for ventriculostomy access device infection in preterm infants.
Topics: Anti-Bacterial Agents; Cerebral Ventriculitis; Drug Monitoring; Female; Humans; Infant, Newborn; Infant, Premature; Male; Retrospective Studies; Vancomycin; Ventriculostomy | 2018 |
Current Practices of Intraventricular Antibiotic Therapy in the Treatment of Meningitis and Ventriculitis: Results from a Multicenter Retrospective Cohort Study.
Topics: Adult; Aged; Aminoglycosides; Anti-Bacterial Agents; Cerebral Ventriculitis; Cerebrospinal Fluid; Critical Care; Female; Gentamicins; Humans; Injections, Intraventricular; Intensive Care Units; Male; Meningitis; Middle Aged; Outcome Assessment, Health Care; Retrospective Studies; Tobramycin; Vancomycin | 2019 |
CSF penetration of vancomycin in critical care patients with proven or suspected ventriculitis: a prospective observational study.
Topics: Administration, Intravenous; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Biostatistics; Cerebral Ventriculitis; Cerebrospinal Fluid; Critical Care; Female; Humans; Male; Middle Aged; Prospective Studies; Serum; Surgical Wound Infection; Vancomycin; Young Adult | 2019 |
Diffusion magnetic resonance imaging diagnostic relevance in pyogenic ventriculitis with an atypical presentation: a case report.
Topics: Aged; Anti-Bacterial Agents; Cerebral Ventriculitis; Diffusion Magnetic Resonance Imaging; Humans; Lateral Ventricles; Male; Methicillin-Resistant Staphylococcus aureus; Radiography; Reproducibility of Results; Sensitivity and Specificity; Staphylococcal Infections; Treatment Outcome; Vancomycin | 2014 |
An infant with an MRSA ventriculo-gallbladder shunt infection.
Topics: Anti-Bacterial Agents; Cerebral Ventriculitis; Cerebrospinal Fluid Shunts; Drug Administration Schedule; Female; Gallbladder; Humans; Infant; Injections, Intraventricular; Methicillin-Resistant Staphylococcus aureus; Staphylococcal Infections; Treatment Outcome; Vancomycin | 2011 |
Prolonged triple therapy for persistent multidrug-resistant Acinetobacter baumannii ventriculitis.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Anti-Bacterial Agents; Cerebral Ventriculitis; Colistin; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Rifampin; Tobramycin; Treatment Outcome; Vancomycin | 2011 |
Antibacterial therapeutic drug monitoring in cerebrospinal fluid: difficulty in achieving adequate drug concentrations.
Topics: Adult; Anti-Bacterial Agents; Cerebral Ventriculitis; Drug Monitoring; Drug Therapy, Combination; Humans; Hydrocephalus; Male; Meropenem; Subarachnoid Hemorrhage; Thienamycins; Vancomycin; Ventriculostomy | 2013 |